PainReform Ltd.
PRFX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $86 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $16 | $15 | $15 | $7 |
| Gross Profit | -$16 | -$15 | $71 | -$7 |
| % Margin | – | – | 82.6% | – |
| R&D Expenses | $11,705 | $6,035 | $4,422 | $2,860 |
| G&A Expenses | $2,968 | $3,483 | $4,447 | $4,348 |
| SG&A Expenses | $2,952 | $3,549 | $4,447 | $4,348 |
| Sales & Mktg Exp. | $0 | $66 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $14,657 | $9,584 | $8,869 | $7,208 |
| Operating Income | -$14,673 | -$9,584 | -$8,869 | -$7,208 |
| % Margin | – | – | -10,312.8% | – |
| Other Income/Exp. Net | $93 | $248 | $86 | -$32 |
| Pre-Tax Income | -$14,580 | -$9,336 | -$8,783 | -$7,240 |
| Tax Expense | $8 | $8 | $9 | $6 |
| Net Income | -$14,588 | -$9,344 | -$8,792 | -$7,246 |
| % Margin | – | – | -10,223.3% | – |
| EPS | -32.16 | -171.329 | -197.921 | -177.233 |
| % Growth | 81.2% | 13.4% | -11.7% | – |
| EPS Diluted | -32.16 | -171.329 | -197.921 | -177.233 |
| Weighted Avg Shares Out | 454 | 55 | 44 | 41 |
| Weighted Avg Shares Out Dil | 454 | 55 | 44 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | $101 | $406 | $160 | $0 |
| Interest Expense | $14 | $384 | $61 | $10 |
| Depreciation & Amortization | $16 | $15 | $15 | $7 |
| EBITDA | -$14,550 | -$9,569 | -$8,755 | -$7,201 |
| % Margin | – | – | -10,180.2% | – |